Redeye: AlzeCure Pharma (Q1 Review): Advancing toward Phase IIa with NeuroRestore ACD856
Idag, 10:16
Idag, 10:16
Redeye’s analyst just published a Research Update on AlzeCure Pharma.
Click here to read the article
Make sure to add AlzeCure Pharma to your Watchlist at Redeye and our analysts will notify you if anything relevant happens regarding your companies.
This is a press release from Redeye - Nordic Growth. www.redeye.se
Attachments
AlzeCure Pharma (Q1 Review): Advancing toward Phase IIa with NeuroRestore ACD856
Idag, 10:16
Redeye’s analyst just published a Research Update on AlzeCure Pharma.
Click here to read the article
Make sure to add AlzeCure Pharma to your Watchlist at Redeye and our analysts will notify you if anything relevant happens regarding your companies.
This is a press release from Redeye - Nordic Growth. www.redeye.se
Attachments
AlzeCure Pharma (Q1 Review): Advancing toward Phase IIa with NeuroRestore ACD856
Rapporter
Analys
Lyxsektorn
Svensk ekonomi
Rapporter
Analys
Lyxsektorn
Svensk ekonomi
1 DAG %
Senast
OMX Stockholm 30
−1,27%
(12:14)
Sagax D
Idag, 11:10
Sagax minskar förvaltningsresultatet
OMX Stockholm 30
1 DAG %
Senast
3 072,02